tiprankstipranks
Plus Therapeutics (PSTV)
NASDAQ:PSTV
US Market
PSTV
Plus Therapeutics
RESEARCH TOOLSreports
Want to see PSTV full AI Analyst Report?

Plus Therapeutics (PSTV) Income Statement

1,715 Followers

Plus Therapeutics Income Statement

Last quarter (Q4 2025), Plus Therapeutics's total revenue was $1.37M, a decrease of -3.19% from the same quarter last year. In Q4, Plus Therapeutics's net income was $-5.71M. See Plus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 5.21M$ 5.82M$ 4.91M$ 224.00K$ 0.00
Gross Profit
$ 4.77M$ 4.97M$ -4.78M$ -488.00K$ -66.00K
Operating Expenses
$ 20.07M$ 19.67M$ 8.54M$ 19.22M$ 12.43M
Depreciation and Amortization
$ 445.00K$ 852.00K$ 628.00K$ 712.00K$ 419.00K
EBITDA
$ -14.85M$ -8.40M$ -12.69M$ -18.85M$ -12.05M
Operating Income
$ -15.30M$ -14.70M$ -13.32M$ -19.71M$ -12.49M
Other Income/Expenses
$ -7.09M$ 1.72M$ 5.00K$ -563.00K$ -907.00K
Pretax Income
$ -22.39M$ -12.98M$ -13.32M$ -20.27M$ -13.40M
Net Income
$ -22.39M$ -12.98M$ -13.32M$ -20.27M$ -13.40M
Per Share Metrics
Basic EPS
$ -7.19$ -48.75K$ -106.00K$ -288.75K$ -444.50K
Diluted EPS
$ -7.19$ -58.50K$ -106.00K$ -288.75K$ -444.50K
Weighted Average Shares Outstanding
 3.11M----
Weighted Average Shares Outstanding (Diluted)
 3.11M----
Currency in USD

Plus Therapeutics Earnings and Revenue History